AMLX Sale Disclosure
Bedrosian Camille L · SEC Form 4 · Filed Sep 14, 2026
Sale
Calculated transaction value
$68.86K
Bedrosian Camille L Chief Medical Officer
AMLX
Transaction date
Sep 10, 2026
Public filing date
Sep 14, 2026
Filing lag
Filed 4 days later
AMLX daily price context
Close on/before transaction
$32.09
Sep 10, 2026
Close before public filing
$31.62
Sep 11, 2026
Return since public filing
+4.36%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,081 shares @ $33.09
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-390510
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$324.87K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. AMLX | Sale | Sep 10, 2026 | $256K |
| Amylyx Pharmaceuticals, Inc. AMLX Current | Sale | Sep 10, 2026 | $68.86K |